Sanofi to sell the drugs factory Zentiva from Bucharest

Newsroom 01/11/2016 | 11:20

The French group Sanofi intends to sell the generic drugs division from Europe, which will have effects also on the Romanian market, with Zentiva factory being owned by Sanofi since 2009 and being put up for sale mow, according to a release published on the Bucharest Stock Exchange.

The announcement made at the same time with the launch of the 2020 strategy. Sanofi has carefully analyzed all the available options regarding the future of the strategy of the generic division in Europe and decided to start the separation process.

„The generics activity remains an important one for Sanofi in other parts of the world, continuing to consolidate the contribution in this domain in the emergent markets, ” says Emmanuelle Valentin, the president of the Administration Council of Zentiva.